Research Links Sglt2 Inhibitors To Increased Risk For Vaginal Candidiasis | Latest News RSS feed

Research Links Sglt2 Inhibitors To Increased Risk For Vaginal Candidiasis - Latest News


Research links SGLT2 inhibitors to increased risk for vaginal candidiasis

A study in the Journal of Diabetes Investigation showed that women with type 2 diabetes were at an increased risk for vaginal candidiasis and symptomatic vaginitis after six months of initiating SGLT2 ... read more

Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus

Daily urinary glucose excretion increased in a dose-dependent manner with dapagliflozin ... Dapagliflozin, a selective SGLT2 inhibitor, has previously been shown to induce dose-dependent glucosuria in ... read more

FDA Issues Complete Response Letter for Canagliflozin/Metformin Fixed-Dose Combination Therapy for Type 2 Diabetes

RARITAN, N.J., Dec. 12, 2013 /PRNewswire/ -- Janssen Research & Development ... is an oral medication that selectively inhibits sodium glucose co-transporter 2 (SGLT2), a carrier responsible for the r... read more

Looking for another news?


U.S. FDA Approves INVOKANA™ (Canagliflozin) for the Treatment of Adults with Type 2 Diabetes

INVOKANA™ selectively inhibits SGLT2 ... risk of dehydration if you: have low blood pressure take medicines to lower your blood pressure, including diuretics (water pill) are on low sodium (salt) diet ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us